Chen, L., Yang, L., Wang, J., Liang, R., Li, H., Tan, K., Wang, L., Niu, T., Zhao, W. (2025). High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory diffuse large B-cell lymphoma: A single agent phase IIb study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7047